| 15.08.2022 17:37:37 | |
|---|---|
| Cena | |
| 162,20 EUR | |
| Změna | 0,67% (1,08) |
Základní údaje
| ISIN | US4781601046 |
| Symbol | JNJ |
| Burza | Tradegate |
| Měna | EUR |
| Sektor | Chemical / Pharmaceutical / Health |
| Typ cenného papíru | Akcie |
| Tržní kapitalizace (mil.) | 423.834 EUR |
| Benchmark | S&P 500 |
Tržní data
| Nákup (částka) | 162,42 EUR (350) |
| Prodej (částka) | 162,66 EUR (350) |
| Otevírací cena | 161,88 EUR |
| Max | 163,24 EUR |
| Min | 161,32 EUR |
| Závěrečná cena (předchozí den) | 161,12 EUR |
| Cena vážená obchodovaným objemem | 162,19067 EUR |
| Objem (kusy) | 9.368 |
| Obchodovaný objem | 1.519.464,08 |
| Počet obchodů | 229 |
| Poslední zobchodovaný počet | 102 |
Futures a opce
| Související Futures | 15 |
| Související Opce | - |
PDF ke stažení
| Report společnosti: JOHNSON & JOHNSON |  |
Stupnice: ABS REL
Nástroj/produkt
Přidat benchmark:
Minulá výkonnost nezaručuje výkonnost budoucí.Zdroj: FactSet
Aktuální analýzy a prognózy
| Datum | Nadpis | Stáhnout | |
| 08.08.2022 |
|
Global Equity Ratings |
|
| 25.07.2022 |
|
Global Equity Ratings |
|
| 19.07.2022 |
|
Global Equity Ratings |
|
| 29.06.2022 |
|
Global Equity Ratings |
|
| 25.05.2022 |
|
Global Equity Ratings |
|
Všechny burzy pro JOHNSON & JOHNSON
| Burza | Datum | Čas | Cena | Obchodovaný objem (mil.) | Počet obchodů |
| Xetra | 15.08.2022 | 17:35 | 162,24 EUR | 0,90 | 336 |
| Vienna Stock Exchange | 15.08.2022 | 17:32 | 162,32 EUR | 0,00 | 2 |
| Tradegate | 15.08.2022 | 17:37 | 162,20 EUR | 1,47 | 221 |
| Stuttgart | 15.08.2022 | 17:29 | 162,24 EUR | 0,03 | 10 |
| SIX Swiss Exchange | 30.06.2022 | 17:36 | 168,00 CHF | 0,00 | 1 |
| SIX Swiss Exchange | 30.03.2020 | 17:35 | 150,00 USD | 0,00 | 1 |
| NYSE | 15.08.2022 | 17:37 | 165,18 USD | 537,89 | 57.433 |
| Munich | 15.08.2022 | 15:32 | 162,16 EUR | 0,01 | 3 |
| London Stock Exchange | 15.08.2022 | 17:35 | 165,42 USD | 0,02 | 18 |
| Hanover | 15.08.2022 | 08:21 | 162,02 EUR | 0,00 | 1 |
| Hamburg | 15.08.2022 | 08:08 | 161,62 EUR | 0,00 | 1 |
| Frankfurt | 15.08.2022 | 17:35 | 162,30 EUR | 0,22 | 25 |
| Duesseldorf | 15.08.2022 | 16:01 | 162,54 EUR | 0,00 | 8 |
| Berlin | 15.08.2022 | 08:08 | 161,90 EUR | 0,00 | 1 |
| 15.08.2022 17:37:37 | |
|---|---|
| Cena | |
| 162,20 EUR | |
| Změna | 0,67% (1,08) |
Základní údaje
| ISIN | US4781601046 |
| Symbol | JNJ |
| Burza | Tradegate |
| Měna | EUR |
| Sektor | Chemical / Pharmaceutical / Health |
| Typ cenného papíru | Akcie |
| Tržní kapitalizace (mil.) | 423.834 EUR |
| Benchmark | S&P 500 |
Tržní data
| Nákup (částka) | 162,42 EUR (350) |
| Prodej (částka) | 162,66 EUR (350) |
| Otevírací cena | 161,88 EUR |
| Max | 163,24 EUR |
| Min | 161,32 EUR |
| Závěrečná cena (předchozí den) | 161,12 EUR |
| Cena vážená obchodovaným objemem | 162,19067 EUR |
| Objem (kusy) | 9.368 |
| Obchodovaný objem | 1.519.464,08 |
| Počet obchodů | 229 |
| Poslední zobchodovaný počet | 102 |
Výkonnost a riziko
| 6m | 1r | 3r | |
| Výkonn. (%) | +9,07% | +7,93% | +36,57% |
| Výkonn. (abs.) | +13,40 | +11,84 | +43,14 |
| Beta | 0,32 | 0,30 | 0,62 |
| Volatilita | 22,17 | 19,28 | 22,72 |
Stupnice: ABS REL
Nástroj/produkt
Přidat benchmark:
Minulá výkonnost nezaručuje výkonnost budoucí.Zdroj: FactSet
Ceny
| Ø cena 5 dní| Ø objem 5 dní (ks.) | 164,51 EUR (9.184) |
| Ø cena 30 dní| Ø objem 30 dní (ks.) | 170,53 EUR (6.292) |
| Ø cena 100 dní| Ø objem 100 dní (ks.) | 167,99 EUR (6.070) |
| Ø cena 250 dní| Ø objem 250 dní (ks.) | 154,79 EUR (8.590) |
| YTD Max| datum | 178,20 EUR (12.07.2022) |
| YTD Min | datum | 131,50 EUR (21.02.2022) |
| 52týdenní max. | datum | 178,20 EUR (12.07.2022) |
| 52týdenní min. | datum | 131,50 EUR (21.02.2022) |
Logo společnosti
Kontakty
| JOHNSON & JOHNSON |
| - - |
| One Johnson & Johnson Plaza - 08933 New Brunswick |
| Telefon:1-732-524-0400 |
| Fax:- |
| E-mail:- |
PDF ke stažení
| Report společnosti: JOHNSON & JOHNSON | |
Profil společnosti
Johnson & Johnson is a holding company, which engages in the research and development, manufacture and sale of products in the health care field. It operates through the following segments: Consumer Health, Pharmaceutical, and Medical Devices. The Consumer Health segment includes products used in the baby care, oral care, beauty, over-the-counter pharmaceutical, women's health, and wound care markets. The Pharmaceutical segment focuses on therapeutic areas, such as immunology, infectious diseases, neuroscience, oncology, pulmonary hypertension, and cardiovascular & metabolic diseases. The Medical Devices segment offers products used in the orthopedic, surgery, cardiovascular & neurovascular, and eye health fields. The company was founded by Robert Wood Johnson I, James Wood Johnson and Edward Mead Johnson Sr. in 1886 and is headquartered in New Brunswick, NJ. |
Členové představenstva
| Alex Gorsky | Chairman of Board of Directors |
| A. Washington | Member of Board of Directors |
| Jennifer Doudna | Member of Board of Directors |
| Mark McClellan | Member of Board of Directors |
| Mary Beckerle | Member of Board of Directors |
| Nadja West | Member of Board of Directors |
| Anne Mulcahy | Member of Board of Directors |
| D. Davis | Member of Board of Directors |
| Darius Adamczyk | Member of Board of Directors |
| Hubert Joly | Member of Board of Directors |
| Ian Davis | Member of Board of Directors |
| Marillyn Hewson | Member of Board of Directors |
| Mark Weinberger | Member of Board of Directors |
| Joaquin Duato | Chairman of Managing Board |
| Mathai Mammen | Member of Executive Committee |
| Peter M. Fasolo | Member of Executive Committee |
| William N. Hait | Member of Executive Committee |
| Ashley McEvoy | Member of Executive Committee |
| James Swanson | Member of Executive Committee |
| Jennifer Taubert | Member of Executive Committee |
| Joseph Wolk | Member of Executive Committee |
| Kathryn E. Wengel | Member of Executive Committee |
| Michael H. Ullmann | Member of Executive Committee |
| Thibaut Mongon | Member of Executive Committee |
| Vanessa Broadhurst | Member of Executive Committee |